跳至主要内容
临床试验/NCT01406652
NCT01406652已完成不适用

One-stage Versus Two-stage Surgical Treatment of Infectious Bursitis

University Hospital, Geneva2 个研究点 分布在 1 个国家目标入组 224 人开始时间: 2011年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
224
试验地点
2
主要终点
Overall Costs of the Combined Surgical and Medical Treatment

研究概览

简要总结

The study investigates prospectively the cost-savings related to a one-stage bursectomy (debridement, drainage and closure at the same time) versus two-stage bursectomy (debridement, left open and closure at a second time) of severe bursitis among hospitalized patients for surgical treatment of septic bursitis.

We suppose that the one-stage bursectomy reveals similar recurrence rates but is associated with a significant shortening of hospital stay, consumption of resources and increased patient satisfaction.

详细描述

Start as single center interventional study at Geneva University Hospitals Study open for additional centres (electronic CRF) Funding on 24.6.2011 (50,000 Swiss Francs). Further demand for funding ongoing.

Septic bursitis of knee and elbows, for which the patients are hospitalised (a substantial part of patient with failure of conservative treatment) Randomisation 1:1 (one-stage vs. two-stage).

Duration of concomitant postsurgical antibiotic therapy fixed to 7 days Exclusion of severely immuno-depressed patients.

Assessment of all costs of inpatient treatment and outpatient follow-up of included cases.

Interim analysis after ca. 100 cases planified.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age >18 years
  • Hospitalized for bursectomy for septic bursitis

排除标准

  • Bacteraemic diseases
  • Presence of another concomitant infection requiring antibiotics
  • Presence of osteosynthesis material beneath the bursitis
  • Septic bursitis outside of the elbow or the knee
  • Severe immune suppression (transplantation, HIV with Cluster of Differentiation cell count <200 cells/mm3, immune suppressive treatment with equivalence of more than 15 mg of prednisone daily ).
  • Recurrent septic bursitis episodes

结局指标

主要结局

Overall Costs of the Combined Surgical and Medical Treatment

时间窗: 2 months

The overall costs are of primary interest in the study protocol.

次要结局

  • Number of Participants With Post-surgical Wound Dehiscence(2 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ilker Uckay

PD Dr. med, MD, Attending

University Hospital, Geneva

研究点 (2)

Loading locations...

相似试验